Conrad Wang has left Medtronic, where he oversaw corporate venturing investments and acquisitions, to join investment firm Healthcare Royalty Partners.
Conrad Wang has left US-based medical device maker Medtronic, where he was a senior director of corporate development, to take up a position at healthcare investment firm Healthcare Royalty Partners (HCRP).
Wang joined Medtronic in 2013 and led cross-functional teams that made acquisitions and minority investments, and formed strategic alliances and joint ventures. He will be principal on US-based HCRP’s investment team
Gregory Brown, founder and managing director of HCRP, said yesterday: “Dr. Wang’s impressive background as an orthopaedic surgeon;…
